
Omicron week in review, Jan.3-8
Hospitals in trouble, Moderna booster = 62.5% effectiveness, Supremes hear mandate arguments, get-used-it strategies the new COVID-19 normal, CDC soft pedals testing, and FDA OKs young teen booster
Ashish Jha: Yes, fewer hospitalizations from omicron but hospitals still in trouble
In a 14-tweet thread this afternoon, Jha discusses the trend of fewer hospitalizations from COVID-19 caused by the omicron variant but, in his words, “our healthcare system is in trouble.” Tis a seeming contradiction. But Jha tweets that those being hospitalized are either unvaccinated or high-risk individuals who are vaccinated but not boosted. By his reckoning there is a pool of about 40 million Americans who, even if the omicron variant does tend to result in milder disease, remain at risk for hospitalization because of their vaccination/booster/underlying health status. Jha’s prescription hews pretty closely to the conventional wisdom about how to deal with the omicron phase of the pandemic: ramp up vaccination and boosters, now and as fast as possible. He also endorses the pages from public health playbook: more testing, more avoidanceof indoor crowds and more mask wearing indoors.
Moderna booster 62.5% effective against omicron
Results reported in an
Supreme Court hears arguments on mandates
The Supreme Court heard oral arguments on Friday (Jan. 7) about lawsuits challenging the Biden administration’s vaccine mandates. Amy Howe of the
Biden transition COVID-19 advisers call for “new normal” approach to COVID-19
In three opinion pieces published online in JAMA on Thursday (Jan. 6), Ezekiel Emanuel, M.D., Ph.D., Michael Osterholm, Ph.D., M.P.H., Celine Gounder, M.D., Sc.M., and others called for a new approach to COVID-19 that would recognize that the disease is going to be a permanent.
Some of the points made in the viewpoints would attract little opposition: greater investment in disease surveillance, more “data infrastructure,” and a research push into vaccines that would protect against as many variants as possible. Others — more vaccine mandates, setting mortality and morbidity benchmarks for imposing public health restrictions, opt-out digital surveillance of vaccinated people — will stir up controversy and downright opposition. The viewpoints garnered headlines partly because but also stressed that research and healthcare priorities need to shift to as abiding COVID-19, a feature, not a bug, of these times.
Mayo fires 1% of its workforce for not complying with vaccine policy
The
"While Mayo Clinic is saddened to lose valuable employees, we need to take all steps necessary to keep our patients, workforce, visitors and communities safe," the clinic said in a statement, reported the news website.
CDC soft pedals for tests as part of isolation recommendations
The CDC has come criticism for not making a negative test part of its recommendation for ending isolation after contracting COVID-19. The agency mentioned testing in the
More evidence that suggests that the omicron wave is resulting in milder disease
In a preprint published on Tuesday (Jan. 4), researchers at the Houston Methodist healthcare system reported on 1,313 patients with symptomatic cases of COVID-19 caused by the omicron variant. Compared to patients infected with either alpha or delta variants, those with infected with the omicron version of the SARS-CoV-2 virus were “significantly younger, had significantly increased vaccine breakthrough rates, and were significantly less likely to be hospitalized,” the abstract says.
FDA OKs boosters for young teens
The FDA announced on Monday (Jan. 3) that it had amended the emergency use authorization for the Pfizer vaccine to include a booster shot for people ages 12 to 15. The agency also OKed adding a third dose of the Pfizer vaccine to the primary series for immunocompromised children, ages 5 to 11.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.